Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): Initial experience

Investigative Radiology

Volumn 40, Issue 6, 2005, Pages 328-335

  Floery, Daniel ^a   Helbich, Thomas H ^a   Riedl, Christopher C ^a   Jaromi, Silvia ^a   Weber, Michael ^a   Leodolter, Sepp ^a   Fuchsjaeger, Michael H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast neoplasms; Computed tomography laser mammography; Laser technique; Mammography; Optical imaging

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST TUMOR; COMPUTED TOMOGRAPHY LASER MAMMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE RECONSTRUCTION; LASER; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; OPTICAL IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS; TUMOR DIAGNOSIS;

EID: 19544378696     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000164487.60548.28     Document Type: Article

References (40)

1. Heywang SH, Wolf A, Pruss E, et al. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology. 1989;171:95-103.
2. Kopans D. Priorities for improved breast cancer imaging. In: Haus AGYM, ed. A Categorical Course in Physics: Technical Aspects of Breast Imaging. RSNA; 1993.
3. Tohno EC, Cosgrove DO, Sloane JP. Ultrasound Diagnosis of Breast Diseases. NY: Churchill-Livingstone; 1994.
4. Fuchsjager MH, Helbich TH, Ringl H, et al. Electrical impedance scanning in the differentiation of suspicious breast lesions: comparison with mammography, ultrasound and histopathology. Rofo. 2002;174: 1522-1529.
5. Helbich TH, Becherer A, Trattnig S, et al. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology. 1997;202:421-429.
6. Scheidhauer K, Walter C, Seemann MD. FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions. Eur J Nucl Med Mol Imaging. 2004;31(Suppl 1):S70-S79.
7. Lorenzen J, Sinkus R, Adam G. Elastography: quantitative imaging modality of the elastic tissue properties. Rofo. 2003;175:623-630.
8. Bremer C, Bogdanov AA, Weissleder R. Imaging of angiogenesis. Radiologe. 2001;41:138-145.
9. Drexler B, Davis JL, Schofield G. Diaphanography in the diagnosis of breast cancer. Radiology. 1985;157:41-44.
10. Fodor J 3rd, Malott JC, Moskowitz M. Diaphanography: transillumination of the breast. Radiol Technol. 1984;55:97-100.
11. Marshall V, Williams DC, Smith KD. Diaphanography as a means of detecting breast cancer. Radiology. 1984;150:339-343.
12. Monsees B, Destouet JM, Gersell D. Light scan evaluation of nonpalpable breast lesions. Radiology. 1987;163:467-470.
13. Monsees B, Destouet JM, Gersell D. Light scanning of nonpalpable breast lesions: reevaluation. Radiology. 1988;167:352.
14. Monsees B, Destouet JM, Totty WG. Light scanning versus mammography in breast cancer detection. Radiology. 1987;163:463-465.
15. Watmough DJ. A light torch for the transillumination of female breast tissues. Br J Radiol. 1982;55:142-146.
16. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175-203.
17. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 1992;3:65-71.
18. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med. 2003;3:643-651.
19. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
20. Richter DM. Computed tomographic laser mammography, a practical review. Jpn J Radiol Tech. 2003;59:687-693.
21. Imaging Diagnostic Systems 1 2005, IDSI: US.
22. Helbich TH, Matzek W, Fuchsjager MH. Stereotactic and ultrasound-guided breast biopsy. Ear Radiol. 2004;14:383-393.
23. Veltman J, Boetes C, Wobbes T, et al. Magnetic resonance-guided biopsies and localizations of the breast: initial experiences using an open breast coil and compatible intervention device. Invest Radiol. 2005;40:379-384.
24. Rosen PP. Rosen's Breast Pathology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
25. Fless JL. Statistical Methods for Rates and Proportions. New York: Wiley; 1981.
26. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology. 1996;200:639-649.
27. Harms SF, Helsey DK. MR imaging of the breast with rotating delivery of excitation off axis resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493-501.
28. Orel SGS, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology. 1994;190: 485-493.
29. Guidi AJ, Schnitt SJ, Fischer L, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer. 1997;80: 1945-1053.
30. Rice A, Quinn CM. Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. J Clin Pathol. 2002;55:569-574.
31. Furuta AI, Ishibashi T, Takahashi S, et al. Magnetic resonance imaging of breast cancer: correlation between contrast enhancement and tumor angiogenesis. Nippon Igaku Hoshansen Gakkai Zasshi. 1999;59:682-688.
32. Lantzsch T, Hefler L, Krause U, et al. The correlation between immunohistochemically detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer. Anticancer Res. 2002;22:1925-1928.
33. Helbich TH. Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol. 2000;34:208-219.
34. Stoutjesdijk MJ, Fütterer JJ, Boetes C, et al. Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging. Invest Radiol. 2005;40:355-362.
35. Grosenick D, Wabnitz H, Moesta KT, et al. Concentration and oxygen saturation of haemoglobin of 50 breast tumours determined by time-domain optical mammography. Phys Med Biol. 2004;49:1165-1181.
36. Franceschini MA, Moesta KT, Fantini S, et al. Frequency-domain techniques enhance optical mammography: initial clinical results. Proc Natl Acad Sci USA. 1997;94:6468-6473.
37. Ntziachristos V, Yodh AG, Schnall M, et al. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci USA. 2000;97:2767-2772.
38. Bremer C, Ntziachristos V, Mahmood U, et al. [Progress in optical imaging]. Radiologe. 2001;41:131-137.
39. Bremer C, Ntziachristos V, Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol. 2003;13:231-243.
40. Bremer C, Ntziachristos V, Weitkamp B, et al. Optical imaging of spontaneous breast tumors using protease sensing "smart" optical probes. Invest Radiol. 2005;40:321-327.